LOS ANGELES, Sept. 8, 2014 /PRNewswire/ — Pacific Shore Holdings, Inc. (PSHR) today announced that its Nature-Cide division has granted Med-X, Inc. the exclusive rights to its proprietary natural insecticides. Med-X, Inc. has recognized through trial testing that several of the Nature-Cide products effectively combat several species of insects commonly found in both indoor and outdoor marijuana cultivation. Pacific Shore Holdings, Inc. has been accelerating the Company’s Nature-Cide service and product divisions, since its California state licensing and initial EPA registration was completed earlier this year. The recent results of marketing and initial product roll-out have convinced Management and the Board of Directors to make a strategic decision to move expeditiously to accelerate product awareness in the medical marijuana arena through Med-X, Inc.

“This agreement addresses the need for immediate focus on the hydroponic and patient care aspects of medical marijuana cultivation, as there is a constant issue with insects like spider mites, white flies and caterpillars, which are currently being combated with poisons on a national basis,” states Pacific Shore Holdings, Inc. founder Matthew Mills.

The Nature-Cide product is a proven all-natural pesticide, insecticide and repellent that is non-toxic to humans, pets, livestock, and plant life. According to the Nature-Cide website, the Company’s products “Range from outdoor Pest Management Services to a travel Bed Bug Spray. If you have problems with insects and are looking for a cost effective, safe alternative to dangerous insecticides, give Nature-Cide a try. We guarantee you won’t be disappointed.”

Pacific Shore continues to remain positioned at the forefront of developments in the green products sector.

To learn more about Pacific Shore Holdings, Inc. and its product lines, visit www.pac-sh.com. For Product and Service inquires please contact info@pac-sh.com or call (818) 998-0996.  

SOURCE Pacific Shore Holdings, Inc.